1. Bujedo BM. Spinal opioid bioavailability in postoperative pain. Pain Pract 2014; 14: 350-364. DOI: 10.1111/papr.12099.
2.
Sabbe MB, Yaksh TL. Pharmacology of spinal opioids. J Pain Symptom Manage 1990; 5: 191-203. DOI: 10.1016/0885-3924(90)90009-9.
3.
Maruyama N, Wakimoto M, Inamori N, Nishimura S, Mori T. Anesthetic management of three patients with chronic inflammatory demyelinating polyradiculoneuropathy. Masui 2015; 64: 852-855 [Article in Japanese].
4.
Gogia B, Rocha Cabrero F, Khan Suheb MZ, Rai PK. Chronic inflammatory demyelinating polyradiculoneuropathy. Treasure Island (FL): StatPearls; 2023.
5.
Takegami N, Sakuishi K, Yamaguchi-Takegami N, Egashira S, Komaki S, Mutoh T, Toda T. Anti-lactosylceramide antibody positive combined central peripheral demyelination emerging from long-standing juvenile-onset chronic inflammatory polyradiculoneuropathy; a report of two cases. J Neuroimmunol 2023; 378: 578086. DOI: 10.1016/j.jneuroim.2023.578086.
6.
Gupta B, Agrawal P, D’Souza N, Sawhney C. Anaesthetic management and implications of a case of chronic inflammatory demyelinating polyneuropathy. Indian J Anaesth 2011; 55: 277-279. DOI: 10.4103/0019-5049.82683.
7.
McCombe PA, Hardy TA, Nona RJ, Greer JM. Sex differences in Guillain Barré syndrome, chronic inflammatory demyelinating polyradiculoneuropathy and experimental autoimmune neuritis. Front Immunol 2022; 13: 1038411. DOI: 10.3389/fimmu.2022.1038411.
8.
Rzepinski L, Doneddu PE, Cutelle C, Zawadka-Kunikowska M, Nobile-Orazio E. Autonomic nervous system involvement in chronic inflammatory demyelinating polyradiculoneuropathy: a literature review. Neurol Sci 2023; 44: 3071-3082. DOI: 10.1007/s10072-023-06802-z.
9.
Reynolds J, Sachs G, Stavros K. Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): clinical features, diagnosis, and current treatment strategies. R I Med J (2013) 2016; 99: 32-35.
10.
Takekawa D, Nakai K, Kinoshita H, Saito J, Kitayama M, Kushikata T, Hirota K. Anesthetic management of a patient with chronic inflammatory demyelinating polyneuropathy by combination of total intravenous and regional anesthesia. JA Clin Rep 2019; 5: 19. DOI: 10.1186/s40981-019-0241-2.
11.
Wells AV, Akerman M, Weinberg RY. Neuraxial anesthesia and lower extremity peripheral nerve blocks for ankle surgery in a patient with chronic inflammatory demyelinating polyneuropathy: a case report. A A Pract 2020; 14: 51-53. DOI: 10.1213/XAA.0000000000001140.
12.
Bujedo BM, Santos SG, Azpiazu AU. A review of epidural and intrathecal opioids used in the management of postoperative pain. J Opioid Manag 2012; 8: 177-192. DOI: 10.5055/jom.2012.0114.
13.
Congedo E, Sgreccia M, De Cosmo G. New drugs for epidural analgesia. Curr Drug Targets 2009; 10: 696-706. DOI: 10.2174/138945009788982441.
14.
de Leon-Casasola OA, Parker B, Lema MJ, Harrison P, Massey J. Postoperative epidural bupivacaine-morphine therapy. Experience with 4,227 surgical cancer patients. Anesthesiology 1994; 81: 368-375. DOI: 10.1097/00000542-199408000-00015.
15.
Ready LB, Loper KA, Nessly M, Wild L. Postoperative epidural morphine is safe on surgical wards. Anesthesiology 1991; 75: 452-456. DOI: 10.1097/00000542-199109000-00012.
16.
Wu CL, Cohen SR, Richman JM, Rowlingson AJ, Courpas GE, Cheung K, et al. Efficacy of postoperative patient-controlled and continuous infusion epidural analgesia versus intravenous patient-controlled analgesia with opioids: a meta-analysis. Anesthesiology 2005; 103: 1079-1088; quiz 1109-1010. DOI: 10.1097/00000542-200511000-00023.
17.
American Society of Anesthesiologists Task Force on Neuraxial Opioids; Horlocker TT, Burton AW, Connis RT, Hughes SC, Nickinovich DG, Palmer CM, et al. Practice guidelines for the prevention, detection, and management of respiratory depression associated with neuraxial opioid administration. Anesthesiology 2009; 110: 218-230. DOI: 10.1097/ALN.0b013e31818ec946.
This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
